Masashi Wakabayashi

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. · The Lancet · 2022 · 1.5K citations

Surgical Oncology, Medicine, Cancer Management +10

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)

Shota Fukuoka, Hiroki Hara, Naoki Takahashi et al. · Journal of Clinical Oncology · 2020 · 887 citations · Full text

A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer

Kenji Suzuki, Shun‐ichi Watanabe, Masashi Wakabayashi et al. · Journal of Thoracic and Cardiovascular Surgery · 2020 · 363 citations · Full text

Single-arm Study, Surgical Oncology, Medical Imaging +11

Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial

Akihito Kawazoe, Shota Fukuoka, Yoshiaki Nakamura et al. · The Lancet Oncology · 2020 · 258 citations

Gastrointestinal Oncology, Advanced Gastric Cancer, Medicine +8

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602

Takashi Onda, Toyomi Satoh, Toshiaki Saito et al. · European Journal of Cancer · 2016 · 246 citations

Gynecologic Surgery, Surgical Oncology, Treatment Invasiveness +11